E01P0019 Human Pancreatic Derived Factor ELISA kit
The Human Pancreatic Derived Factor ELISA kit can be used to identify samples from the human species. Pancreatic Derived Factor can also be called ORF9, PANDER, PRED44, C21orf11, C21orf76, Cytokine-like protein 2-21, Family With Sequence Similarity 3, Member B.
Product Information | |
Cat. No. | E01P0206 |
Product Name | Human Pancreatic Derived Factor ELISA kit |
Species | Human |
Product Size | 48 Tests / 96 Tests |
Concentration | 100-2500 pg/ml |
Sensitivity | 1.0 pg/ml |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 pg/mL | 1 vial |
STANDARD B (0.5mL) | 100 pg/mL | 1 vial |
STANDARD C (0.5mL) | 250 pg/mL | 1 vial |
STANDARD D (0.5mL) | 500 pg/mL | 1 vial |
STANDARD E (0.5mL) | 1000 pg/mL | 1 vial |
STANDARD F (0.5mL) | 2500 pg/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
| PANDER ELISA kit uses an anti-PANDER antibody and an PANDER-HRP conjugate in a competitive enzyme immunoassay method. PANDER-HRP conjugate is incubated with the assay sample and buffer in a pre-coated plate for one hour. The wells are decanted and washed five times when the incubation period is over. The HRP enzyme substrate is then incubated in the wells. The result of the enzyme-substrate reaction is a complex that is blue in hue. The process is finally stopped by adding a stop solution, causing the solution to turn yellow. In a microplate reader, the color intensity is measured spectrophotometrically at 450 nm. Due to competition for the anti-PANDER antibody binding site between PANDER from samples and PANDER-HRP conjugate, the intensity of the color is inversely proportional to the concentration of PANDER. Since the number of sites is limited, as more sites are occupied by PANDER from the sample, fewer sites are left to bind PANDER-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The PANDER concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% ＜10% | |
Inter Variation% ＜12% | ||
Recovery | 95-102% | |
Linearity | Diluent Ratio | Range % |
1:2 | 93-105 | |
1:4 | 88-106 | |
1:8 | 86-108 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between PANDER and analogues was observed. | |
E01P0206 has been referenced in the below publications：
Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
Related Bluegene Biotech Products
BlueGene Biotech News
